2025. Neuregulin-4 (Nrg-4) as a Metabolic Regulator: A Comprehensive Review of Its Association with Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus. Vascular and Endovascular Review. 8, 19s (Dec. 2025), 177–181. DOI:https://doi.org/10.64149/J.Ver.8.19s.177-181.